Alibaba’s New Model Might Give US Rivals A Run For Their Money, And AstraZeneca And Bristol Myers Squibb Could Join Forces

from The Finimize Daily Brief · host Finimize

Chinese tech titan Alibaba is making its latest and greatest model available open-weight, and making a bid for AI dominance – while AstraZeneca and Bristol Myers Squibb are reportedly considering joining forces, but it’s proving a bitter pill for investors to swallow.Today’s stories:Alibaba’s Latest Model Might Spell Trouble For American AI GiantsThis Massive Merger Could Be Biggest Pharma Deal In HistoryTry Finimize Pro

Episode metadata supplied by the publisher feed · Published Aug 4, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Alibaba’s New Model Might Give US Rivals A Run For Their Money, And AstraZeneca And Bristol Myers Squibb Could Join Forces

0:00 4:34

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Finimize Daily Brief?

This episode is 4 minutes long.

When was this The Finimize Daily Brief episode published?

This episode was published on August 4, 2026.

Can I download this The Finimize Daily Brief episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!